The purpose of this survey is to
assess participants perceptions of the effects of the Medicare Drug
Demonstration (MMA Section 641) on access to care and healthy
outcomes. Survey results are necessary for CMS to complete its
mandated Report to Congress. Due to the complexities of the
demonstration, its implementation has been delayed. Emergency
clearance is requested so that cms may meet the statutory deadlines
for submitting the Report to Congress.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.